MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 255 filers reported holding MYRIAD GENETICS INC in Q2 2016. The put-call ratio across all filers is 3.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,752,000 | +157.4% | 248,504 | +124.4% | 0.00% | 0.0% |
| Q4 2016 | $1,846,000 | -21.5% | 110,742 | -3.1% | 0.00% | 0.0% |
| Q3 2016 | $2,352,000 | +211.9% | 114,272 | +363.7% | 0.00% | +100.0% |
| Q2 2016 | $754,000 | -40.0% | 24,646 | -26.9% | 0.00% | -33.3% |
| Q1 2016 | $1,256,000 | +162.2% | 33,708 | +139.8% | 0.00% | +200.0% |
| Q4 2014 | $479,000 | -100.0% | 14,056 | -99.3% | 0.00% | -99.1% |
| Q3 2014 | $82,313,627,000 | +15.0% | 2,134,136 | +16.0% | 0.11% | +23.6% |
| Q2 2014 | $71,590,654,000 | +25.5% | 1,839,431 | +10.2% | 0.09% | +39.1% |
| Q1 2014 | $57,060,751,000 | +42.8% | 1,668,931 | -12.3% | 0.06% | +28.0% |
| Q4 2013 | $39,946,969,000 | +361.0% | 1,904,050 | +416.4% | 0.05% | +138.1% |
| Q3 2013 | $8,665,625,000 | +59.3% | 368,750 | +82.2% | 0.02% | +50.0% |
| Q2 2013 | $5,438,488,000 | – | 202,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |